Header Logo

Abde Abukhdeir

Concepts (234)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
11
2020
409
1.220
Why?
Drug Resistance, Neoplasm
5
2020
63
0.790
Why?
Phosphatidylinositol 3-Kinases
4
2016
42
0.780
Why?
Cyclin-Dependent Kinase Inhibitor p21
4
2012
20
0.760
Why?
Epithelial Cells
7
2018
84
0.720
Why?
Cell Proliferation
10
2020
178
0.600
Why?
Estrogen Receptor alpha
3
2012
15
0.580
Why?
Cytostatic Agents
1
2016
2
0.520
Why?
Mutation
7
2021
353
0.510
Why?
Lithium
6
2005
19
0.500
Why?
Gene Expression Regulation, Neoplastic
6
2020
112
0.490
Why?
Aspirin
1
2016
84
0.480
Why?
Breast
4
2011
26
0.460
Why?
Tamoxifen
2
2014
28
0.410
Why?
Cell Line, Tumor
12
2020
249
0.400
Why?
Magnesium
4
2004
36
0.330
Why?
Cell Transformation, Neoplastic
3
2018
30
0.330
Why?
Proto-Oncogene Proteins p21(ras)
3
2018
21
0.310
Why?
Cyclin-Dependent Kinase Inhibitor p27
1
2008
8
0.300
Why?
Antineoplastic Agents
2
2019
190
0.290
Why?
MAP Kinase Signaling System
3
2019
37
0.280
Why?
Phosphorylation
5
2016
149
0.250
Why?
Neoplasms
1
2008
239
0.250
Why?
Proto-Oncogene Proteins
2
2017
35
0.240
Why?
Gene Expression Regulation
1
2006
281
0.230
Why?
Humans
29
2021
28395
0.220
Why?
Trastuzumab
2
2020
27
0.220
Why?
Membrane Proteins
2
2020
171
0.220
Why?
Receptor, ErbB-2
2
2020
50
0.210
Why?
Class I Phosphatidylinositol 3-Kinases
4
2016
9
0.200
Why?
Estrogens
2
2014
24
0.180
Why?
Bipolar Disorder
5
2004
132
0.180
Why?
Female
15
2020
15704
0.180
Why?
STAT6 Transcription Factor
1
2020
11
0.170
Why?
Neoadjuvant Therapy
1
2020
66
0.170
Why?
Antineoplastic Agents, Immunological
1
2020
17
0.170
Why?
Triple Negative Breast Neoplasms
1
2020
17
0.170
Why?
Class Ia Phosphatidylinositol 3-Kinase
1
2019
4
0.160
Why?
Receptors, Estrogen
2
2017
60
0.160
Why?
Mice
6
2020
1461
0.160
Why?
Protein Kinase Inhibitors
1
2019
50
0.160
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
241
0.160
Why?
Animals
8
2020
3780
0.160
Why?
Carcinoma, Non-Small-Cell Lung
1
2021
244
0.150
Why?
Glycogen Synthase Kinase 3 beta
2
2016
14
0.150
Why?
Ion Channels
1
2020
234
0.150
Why?
Macrophages
1
2018
108
0.140
Why?
Pancreatic Neoplasms
1
2018
97
0.140
Why?
Lipid Metabolism
1
2017
38
0.140
Why?
MCF-7 Cells
1
2016
13
0.130
Why?
Lung Neoplasms
1
2021
553
0.130
Why?
Gene Targeting
3
2019
10
0.130
Why?
ras Proteins
2
2013
10
0.120
Why?
Erythrocytes
3
2004
20
0.120
Why?
DNA-Binding Proteins
1
2017
274
0.120
Why?
Hydrolases
1
2014
4
0.120
Why?
DNA Repair Enzymes
1
2014
7
0.120
Why?
Ion Transport
2
2003
31
0.110
Why?
Signal Transduction
3
2019
447
0.110
Why?
Precancerous Conditions
2
2018
25
0.100
Why?
Prognosis
3
2014
825
0.100
Why?
Receptors, Androgen
1
2012
6
0.100
Why?
Proto-Oncogene Proteins c-akt
4
2019
50
0.100
Why?
Haploinsufficiency
1
2011
2
0.100
Why?
Magnetic Resonance Spectroscopy
4
2005
41
0.100
Why?
Genomic Instability
1
2011
8
0.100
Why?
Genes, BRCA1
1
2011
12
0.100
Why?
Middle Aged
7
2020
9250
0.090
Why?
Cell Cycle
2
2008
34
0.090
Why?
Tumor Suppressor Protein p53
2
2009
82
0.090
Why?
Lithium Compounds
1
2011
3
0.090
Why?
ErbB Receptors
1
2011
54
0.090
Why?
RNA, Small Interfering
3
2020
79
0.090
Why?
Gene Knockdown Techniques
2
2020
45
0.080
Why?
Carcinoma, Small Cell
1
2009
54
0.080
Why?
Oncogenes
1
2009
11
0.080
Why?
Transcription, Genetic
1
2009
106
0.080
Why?
Treatment Outcome
3
2020
3615
0.080
Why?
Cell Cycle Proteins
1
2008
16
0.080
Why?
Gene Expression Profiling
1
2009
138
0.080
Why?
Cell Nucleus
1
2008
79
0.070
Why?
Selective Estrogen Receptor Modulators
1
2007
4
0.070
Why?
Cell Membrane
2
2005
90
0.070
Why?
Adenocarcinoma
1
2009
147
0.070
Why?
Enzyme Inhibitors
1
2008
120
0.070
Why?
Up-Regulation
3
2017
177
0.070
Why?
DNA Mutational Analysis
1
2007
59
0.070
Why?
Histone-Lysine N-Methyltransferase
1
2007
4
0.070
Why?
Prostatic Neoplasms
1
2009
104
0.070
Why?
Genes, ras
1
2007
13
0.070
Why?
Multiple Myeloma
1
2007
21
0.070
Why?
Repressor Proteins
1
2007
37
0.070
Why?
Mice, Knockout
1
2008
316
0.070
Why?
Heterografts
2
2020
15
0.070
Why?
Polymerase Chain Reaction
1
2007
120
0.070
Why?
Intracellular Fluid
2
2003
4
0.070
Why?
Neuroblastoma
2
2003
19
0.070
Why?
Tumor Cells, Cultured
2
2003
119
0.070
Why?
RNA Interference
3
2014
36
0.070
Why?
DNA Methylation
1
2007
165
0.070
Why?
Response Elements
1
2006
15
0.070
Why?
Mice, Nude
3
2013
24
0.060
Why?
Sequence Analysis, DNA
1
2006
58
0.060
Why?
Estradiol
1
2006
39
0.060
Why?
Dose-Response Relationship, Drug
2
2004
351
0.060
Why?
TOR Serine-Threonine Kinases
2
2019
13
0.060
Why?
Biomarkers, Tumor
2
2019
202
0.060
Why?
Transducin
1
2004
1
0.060
Why?
Guanosine Diphosphate
1
2004
3
0.060
Why?
Antimanic Agents
1
2004
8
0.060
Why?
Cell Line
3
2011
280
0.060
Why?
Chlorides
1
2003
26
0.050
Why?
Glycine
1
2003
12
0.050
Why?
Analysis of Variance
1
2003
269
0.050
Why?
Cobalt
1
2003
113
0.050
Why?
Neoplasm Transplantation
2
2014
13
0.050
Why?
Transgenes
2
2014
14
0.050
Why?
Time Factors
1
2006
1490
0.050
Why?
Proto-Oncogene Proteins c-met
1
2021
3
0.050
Why?
Pyridazines
1
2021
2
0.050
Why?
Piperidines
1
2021
12
0.050
Why?
Benzamides
1
2021
15
0.050
Why?
Exons
1
2021
33
0.050
Why?
Pyrimidines
1
2021
22
0.050
Why?
Models, Biological
1
2003
326
0.050
Why?
Triazines
1
2021
12
0.050
Why?
Gene Knock-In Techniques
2
2013
7
0.050
Why?
Phenotype
2
2014
310
0.050
Why?
Hyaluronoglucosaminidase
1
2020
2
0.050
Why?
Imidazoles
1
2021
55
0.050
Why?
Injections, Subcutaneous
1
2020
25
0.050
Why?
Drug Approval
1
2020
7
0.050
Why?
United States Food and Drug Administration
1
2020
22
0.040
Why?
Multicenter Studies as Topic
1
2020
51
0.040
Why?
Chemotherapy, Adjuvant
1
2020
81
0.040
Why?
Extracellular Signal-Regulated MAP Kinases
2
2012
28
0.040
Why?
Gene Expression
2
2012
202
0.040
Why?
Epithelial-Mesenchymal Transition
1
2020
6
0.040
Why?
Gene Knockout Techniques
1
2020
8
0.040
Why?
Drug Administration Schedule
1
2020
166
0.040
Why?
CRISPR-Cas Systems
1
2020
10
0.040
Why?
Hydrogen Peroxide
1
2020
45
0.040
Why?
Cell Survival
1
2020
120
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2020
94
0.040
Why?
NADPH Oxidases
1
2020
55
0.040
Why?
Cell Movement
1
2020
82
0.040
Why?
Biological Transport
3
2004
40
0.040
Why?
Immunohistochemistry
1
2020
362
0.040
Why?
Neoplasm Metastasis
1
2019
102
0.040
Why?
Randomized Controlled Trials as Topic
1
2020
329
0.040
Why?
RAW 264.7 Cells
1
2018
3
0.040
Why?
Carcinoma, Pancreatic Ductal
1
2018
11
0.040
Why?
Mice, Inbred NOD
1
2018
30
0.040
Why?
Mice, SCID
1
2018
45
0.040
Why?
Transplantation, Heterologous
2
2009
20
0.040
Why?
Carcinogenesis
1
2018
25
0.040
Why?
Adult
3
2020
8097
0.040
Why?
Pancreas
1
2018
33
0.040
Why?
Down-Regulation
2
2009
102
0.040
Why?
Neoplasm Staging
1
2019
371
0.040
Why?
Pre-B-Cell Leukemia Transcription Factor 1
1
2017
1
0.040
Why?
Alleles
2
2007
221
0.030
Why?
Disease Models, Animal
1
2019
619
0.030
Why?
RNA, Messenger
1
2017
308
0.030
Why?
Aged
2
2020
9256
0.030
Why?
Gene Dosage
1
2014
18
0.030
Why?
Phospholipids
2
2005
10
0.030
Why?
Gene Deletion
1
2014
42
0.030
Why?
Base Sequence
1
2014
107
0.030
Why?
Isotopes
2
2005
2
0.030
Why?
Molecular Sequence Data
1
2014
199
0.030
Why?
Binding, Competitive
2
2004
24
0.030
Why?
United States
1
2020
2196
0.030
Why?
Epigenesis, Genetic
1
2014
86
0.030
Why?
Ribosomal Protein S6 Kinases, 90-kDa
1
2013
1
0.030
Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2013
2
0.030
Why?
Cell Growth Processes
1
2013
5
0.030
Why?
Point Mutation
1
2013
27
0.030
Why?
Immunocompromised Host
1
2013
46
0.030
Why?
Metribolone
1
2012
1
0.020
Why?
Tosyl Compounds
1
2012
2
0.020
Why?
Cyclin D1
1
2012
5
0.020
Why?
Anilides
1
2012
7
0.020
Why?
Androgens
1
2012
8
0.020
Why?
Androgen Antagonists
1
2012
5
0.020
Why?
Nitriles
1
2012
14
0.020
Why?
Enzyme Activation
1
2012
120
0.020
Why?
Gene Silencing
1
2011
25
0.020
Why?
In Situ Hybridization, Fluorescence
1
2011
34
0.020
Why?
Sequence Deletion
1
2011
15
0.020
Why?
Recombinant Proteins
1
2012
213
0.020
Why?
PTEN Phosphohydrolase
1
2011
7
0.020
Why?
Mitogen-Activated Protein Kinases
1
2011
33
0.020
Why?
Heterozygote
1
2011
102
0.020
Why?
Aged, 80 and over
1
2020
4851
0.020
Why?
Immunoblotting
1
2011
57
0.020
Why?
Polymorphism, Single Nucleotide
1
2011
284
0.020
Why?
Prostate-Specific Antigen
1
2009
15
0.020
Why?
Glycogen Synthase Kinase 3
1
2009
10
0.020
Why?
Mammary Glands, Human
1
2009
7
0.020
Why?
Protein Kinases
1
2009
13
0.020
Why?
Biopsy
1
2009
220
0.020
Why?
Receptor, Fibroblast Growth Factor, Type 3
1
2007
1
0.020
Why?
Chromosomes, Human, Pair 14
1
2007
2
0.020
Why?
Chromosomes, Human, Pair 4
1
2007
4
0.020
Why?
Translocation, Genetic
1
2007
5
0.020
Why?
Colony-Forming Units Assay
1
2007
5
0.020
Why?
Cell Adhesion
1
2007
32
0.020
Why?
Mitogen-Activated Protein Kinase Kinases
1
2007
12
0.020
Why?
Telomerase
1
2007
9
0.020
Why?
Colorectal Neoplasms
1
2009
112
0.020
Why?
Mutagenesis
1
2007
12
0.020
Why?
Transduction, Genetic
1
2007
15
0.020
Why?
Cell Culture Techniques
1
2007
32
0.020
Why?
Transforming Growth Factor beta
1
2007
87
0.020
Why?
Genetic Vectors
1
2007
60
0.020
Why?
Phosphorus Isotopes
1
2005
1
0.020
Why?
Binding Sites
1
2005
75
0.020
Why?
Protein Binding
1
2005
132
0.020
Why?
Male
3
2009
15269
0.010
Why?
Rod Cell Outer Segment
1
2004
1
0.010
Why?
Guanosine Triphosphate
1
2004
4
0.010
Why?
Spectrometry, Fluorescence
1
2004
9
0.010
Why?
Protein Conformation
1
2004
74
0.010
Why?
Cattle
1
2004
127
0.010
Why?
In Vitro Techniques
1
2004
176
0.010
Why?
Kinetics
1
2004
194
0.010
Why?
Indicators and Reagents
1
2003
12
0.010
Why?
Sodium
1
2003
64
0.010
Why?
Thermodynamics
1
2003
43
0.010
Why?
Fibroblasts
1
2003
59
0.010
Why?
Hydrogen-Ion Concentration
1
2003
149
0.010
Why?
Psychiatric Status Rating Scales
1
2004
324
0.010
Why?
Cells, Cultured
1
2003
539
0.010
Why?
Abukhdeir's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (234)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_